NeuroEM Therapeutics Closes Preliminary Rounds in $5 Million Fairness Elevate to Commercialize Drug-free Alzheimer’s Remedy

NeuroEM Therapeutics, an award-winning clinical-stage biotechnology analysis firm pioneering using radio frequencies to reverse Alzheimer’s illness, has closed preliminary rounds totaling $1.33 million of a $5 million fairness increase with BlueLake.vc.

The Sequence A spherical helps continued progress towards commercialization of NeuroEM’s Transcranial Electromagnetic Remedy (TEMT-RF) to stop and deal with cognitive decline attributable to getting older or Alzheimer’s and different neurodegenerative ailments.

“BlueLake’s help demonstrates the significance of sustaining our momentum within the execution of key medical, regulatory, and industrial milestones on our journey towards a secure, efficient, drug-free therapy for Alzheimer’s dementia and different neurodegenerative ailments,” says Chuck Papageorgiou, CEO of NeuroEM Therapeutics. “It fuels the tireless efforts of our researchers, clinicians, engineers, and your entire NeuroEM staff to revive the hope and dignity Alzheimer’s illness has already stolen from thousands and thousands and to sooner or later stop thousands and thousands extra from dealing with this devastating analysis.”

The fairness spherical is led by BlueLake Associate Jamie Rutledge, who additionally joins the NeuroEM Board of Administrators. Rutledge focuses on early-stage investments in breakthrough applied sciences at BlueLake and is a seasoned expertise investor and government with deep experience in strategic funding and innovation throughout the medical expertise and shopper electronics sectors.

He brings greater than 25 years of expertise to NeuroEM, together with senior management roles at Dyson and Lenovo. He beforehand led Lenovo’s Strategic Enterprise Capital and Open Innovation initiatives and directed expertise scouting and strategic investments at Dyson.

“NeuroEM’s pioneering, non-invasive method to treating and stopping Alzheimer’s represents precisely the sort of patented, deep tech innovation we champion at BlueLake—transformative, defensible, and grounded in scientific rigor. This method to drug-free therapy and prevention of Alzheimer’s holds super promise in tackling a illness that has eluded efficient options for many years,” mentioned Rutledge. “We’re proud to help the development of this groundbreaking expertise, and I’m personally honored to assist information NeuroEM because it brings modern, non-invasive therapies to the forefront of neurodegenerative care.”

Provides Papageorgiou, “Jamie’s background in radio frequency programs, embedded units, and product growth aligns carefully with our core expertise, and his strategic perception shall be a priceless asset as NeuroEM strikes towards commercialization and broader market engagement.”

NeuroEM Therapeutics, a member of StartUp Well being’s Alzheimer’s Moonshot Group, is dedicated to creating, clinically testing, and advertising and marketing its multi-patented TEMT-RF applied sciences that focus on and scale back cognitive decline and restore immune stability within the mind and blood whereas boosting vitality manufacturing in mind cells—essential components for optimum cognitive perform. Early research have demonstrated that, as an Alzheimer’s therapy, TEMT-RF is secure, enhances cognitive perform, and will doubtlessly modify the illness itself.

The corporate’s first industrial product, a light-weight cap designed for at-home use, is at the moment beneath growth and has proven extraordinary promise in preclinical and medical research. Worn for an hour twice each day, the system makes use of brief pulses of vitality in particular ultra-high frequencies to ship a transcranial electromagnetic therapy that improves key bodily elements within the mind on the root of cognitive decline.

BlueLake Ventures invests in utilized deep tech for the way forward for work and well being, expertise outlined by important limitations to entry, akin to robust patent safety or specialised area experience. Its staff consists of skilled operators who’ve constructed and scaled startup firms, held government positions in multi-national firms, constructed partnerships between startups and firms, and deployed strategic enterprise capital in technology-driven companies. By leveraging its experience, assets, and networks, BlueLake goals to speed up the expansion of deep tech improvements that empower each companies and shoppers.